References
- Czeisler MÉ, Lane RI, Petrosky E, Wiley JF, Christensen A, Njai R, Weaver MD, Robbins R, Facer-Childs ER, Barger LK, et al. Mental health, substance use, and suicidal ideation during the COVID-19 pandemic — United States, June 24 –30, 2020. MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69:1049–57. doi:https://doi.org/10.15585/mmwr.mm6932a1.
- Substance Abuse and Mental Health Services Administration. 2019 NSDUH detailed tables [Internet]. 2020 Sep [accessed 2020 Nov9]. https://www.samhsa.gov/data/report/2019-nsduh-detailed-tables.
- Wang QQ, Kaelber DC, Xu R, Volkow ND. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Mol Psychiatry [Internet]. 2020 Sep 14 [accessed 2020 Nov8]. http://www.nature.com/articles/s41380-020-00880-7.
- Volkow ND. Collision of the COVID-19 and addiction epidemics. Ann Intern Med. 2020 Jul 7;173:61–62. doi:https://doi.org/10.7326/M20-1212.
- Michigan Marijuana Regulatory Agency. Marijuana Regulatory Agency Statistical Report [Internet]. 2020 [accessed 2020 Nov10]. https://www.michigan.gov/mra/0,9306,7-386-93032-497635–,00.html.
- Miller K, Laha-Walsh K, Albright DL, McDaniel J. Cannabis use during the COVID-19 pandemic: results from a longitudinal study of cannabis users. J Subst Use. 2021 Feb 14. 1–5. doi:https://doi.org/10.1080/14659891.2021.1885517.
- Vidot DC, Islam JY, Camacho-Rivera M, Harrell MB, Rao DR, Chavez JV, G. Ochoa L, Hlaing WM, Weiner M, Messiah SE, et al. The COVID-19 cannabis health study: results from an epidemiologic assessment of adults who use cannabis for medicinal reasons in the United States. J Addict Dis. 2020 Dec 1;39:26–36. doi:https://doi.org/10.1080/10550887.2020.1811455.
- van Laar MW, Oomen PE, van Miltenburg CJA, Vercoulen E, Freeman TP, Hall WD. Cannabis and COVID-19: reasons for Concern. Front Psychiatry. 2020 Dec 21;11:601653. doi:https://doi.org/10.3389/fpsyt.2020.601653.
- Group WAW. The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and feasibility: ASSIST: development, reliability and feasibility. Addiction. 2002 Sep;97:1183–94. doi:https://doi.org/10.1046/j.1360-0443.2002.00185.x.
- Britannica ProCon. Legal medical marijuana states and DC [Internet]. [accessed Dec 27]. https://medicalmarijuana.procon.org/legal-medical-marijuana-states-and-dc/.
- Hasin D, Walsh C. Trends over time in adult cannabis use: a review of recent findings. Curr Opin Psychol. 2021 Apr;38:80–85. doi:https://doi.org/10.1016/j.copsyc.2021.03.005.
- Ashby NJS. Anonymized location data reveals trends in legal cannabis use in communities with increased mental health risks at the start of the COVID-19 pandemic. J Addict Dis. 2021;39:436–440.
- Tortolani P. Why the pandemic was a breakout moment for the cannabis industry. New York Times [Internet]. 2021 May 31 [accessed 2021 Jul 6]. https://www.nytimes.com/2021/05/31/business/cannabis-marijuana-industry-pandemic-dispensaries.html
- Price E. Covid-19 is helping make 2020 a record year for cannabis sales. Forbes [Internet]. 2020 Aug 3 [accessed 2021 Jul 6]. https://www.forbes.com/sites/emilyprice/2020/08/03/covid-is-helping-make-2020-a-record-year-for-cannabis-sales/.
- Cooper ZD, Adinoff B. Necessity of addressing motivations for cannabis use to guide research. Am J Drug Alcohol Abuse. 2019;45:547–50.doi:https://doi.org/10.1080/00952990.2019.1680991.
- Cooper ZD, Craft RM. Sex-dependent effects of cannabis and cannabinoids: a translational perspective. Neuropsychopharmacology. 2018 Jan;43:34–51. doi:https://doi.org/10.1038/npp.2017.140.
- Hasin DS, Kerridge BT, Saha TD, Huang B, Pickering R, Smith SM, Jung J, Zhang H, Grant BF. Prevalence and correlates of DSM-5 cannabis use disorder, 2012-2013: findings from the national epidemiologic survey on alcohol and related conditions–III. Am J Psychiatry. 2016 Jun;173:588–99. doi:https://doi.org/10.1176/appi.ajp.2015.15070907.